Cardlytics (CDLX) Liabilities and Shareholders Equity (2017 - 2026)

Cardlytics (CDLX) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $263.9 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 28.49% year-over-year to $263.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 29.02% YoY) and the FY2025 annual result came in at $285.6 million, down 27.26% from the prior year.
• Liabilities and Shareholders Equity slipped to $263.9 million in Q1 2026, from $285.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.2 billion in Q1 2022 to a low of $263.9 million in Q1 2026.
• A 5-year average of $592.5 million and a median of $569.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The widest YoY moves for Liabilities and Shareholders Equity: up 20.35% in 2022, down 45.3% in 2022.
• Tracing CDLX's Liabilities and Shareholders Equity over 5 years: stood at $691.2 million in 2022, then declined by 16.94% to $574.1 million in 2023, then plunged by 31.6% to $392.7 million in 2024, then fell by 27.26% to $285.6 million in 2025, then declined by 7.61% to $263.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $263.9 million (Q1 2026), $285.6 million (Q4 2025), and $292.8 million (Q3 2025), per Business Quant data.